IntroductionData on genomic susceptibility for adverse outcomes after hematopoietic stem cell transplantation (HSCT) for recipients are scarce.MethodsWe performed a genome wide association study (GWAS) to identify genes associated with survival/mortality, relapse, and severe graft-versus-host disease (sGvHD), fitting proportional hazard and subdistributional models to data of n=1,392 recipients of European ancestry from three centres.ResultsThe single nucleotide polymorphism (SNP) rs17154454, intronic to the neuronal growth guidant semaphorin 3C gene (SEMA3C), was genome-wide significantly associated with event-free survival (p=7.0x10-8) and sGvHD (p=7.5x10-8). Further associations were detected for SNPs in the Paxillin gene (PXN) with deat...
Copyright © 2007 American Society for Blood and Marrow Transplantation Published by Elsevier Inc.Des...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment for patients ...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment for patients ...
IntroductionData on genomic susceptibility for adverse outcomes after hematopoietic stem cell transp...
IntroductionData on genomic susceptibility for adverse outcomes after hematopoietic stem cell transp...
Allogeneic haemopoietic stem cell transplantation is curative for many patients with haematologic di...
BACKGROUND: Genetic association studies of transplantation outcomes have been hampered by small samp...
AbstractDespite optimal supportive care and high-resolution HLA matching, complications such as GVHD...
In addition to the classical human leukocyte antigen (HLA) genes, the outcomes of post-hematopoietic...
Background. Genetic association studies of transplantation outcomes have been hampered by small samp...
Background. Genetic association studies of transplantation outcomes have been hampered by small samp...
Background.Genetic association studies of transplantation outcomes have been hampered by small sampl...
Contains fulltext : 88164.pdf (publisher's version ) (Open Access)BACKGROUND: Non-...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment for patients ...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment for patients ...
Copyright © 2007 American Society for Blood and Marrow Transplantation Published by Elsevier Inc.Des...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment for patients ...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment for patients ...
IntroductionData on genomic susceptibility for adverse outcomes after hematopoietic stem cell transp...
IntroductionData on genomic susceptibility for adverse outcomes after hematopoietic stem cell transp...
Allogeneic haemopoietic stem cell transplantation is curative for many patients with haematologic di...
BACKGROUND: Genetic association studies of transplantation outcomes have been hampered by small samp...
AbstractDespite optimal supportive care and high-resolution HLA matching, complications such as GVHD...
In addition to the classical human leukocyte antigen (HLA) genes, the outcomes of post-hematopoietic...
Background. Genetic association studies of transplantation outcomes have been hampered by small samp...
Background. Genetic association studies of transplantation outcomes have been hampered by small samp...
Background.Genetic association studies of transplantation outcomes have been hampered by small sampl...
Contains fulltext : 88164.pdf (publisher's version ) (Open Access)BACKGROUND: Non-...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment for patients ...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment for patients ...
Copyright © 2007 American Society for Blood and Marrow Transplantation Published by Elsevier Inc.Des...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment for patients ...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment for patients ...